Sagespring Wealth Partners’s Sanofi SNY Stock Holding History

Sagespring Wealth Partners’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$212K	Buy	4,970 +159	+3%	+$7.11K	﹤0.01%	810
2026 Q1	$232K	Sell	4,811 -2,812	-37%	-$131K	﹤0.01%	739
2025 Q4	$369K	Sell	7,623 -109	-1%	-$5.4K	0.01%	562
2025 Q3	$365K	Sell	7,732 -6,957	-47%	-$336K	0.01%	544
2025 Q2	$710K	Buy	14,689 +3,167	+27%	+$162K	0.02%	358
2025 Q1	$639K	Buy	11,522 +1,806	+19%	+$97.8K	0.02%	334
2024 Q4	$469K	Buy	+9,716	New	+$494K	0.01%	365

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Sagespring Wealth Partners's SNY Position: Q2 2026 in Review

Sagespring Wealth Partners increased its Sanofi (SNY) stake by 3.3% in Q2 2026, buying an estimated $7.11K and bringing the position to 4,970 shares worth $212K. The position accounts for ﹤0.01% of the portfolio, ranked #810.

Sagespring Wealth Partners first reported a position in SNY in Q4 2024 and has held it in 7 quarters since. The position peaked at $710K in Q2 2025. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

Sagespring Wealth Partners held 4,970 shares of Sanofi worth $212K as of Q2 2026.
Sagespring Wealth Partners bought 159 Sanofi shares in Q2 2026, an estimated $7.11K.
Sanofi made up ﹤0.01% of Sagespring Wealth Partners's portfolio in Q2 2026, its #810 holding.
Sagespring Wealth Partners first reported a position in Sanofi in Q4 2024 and has held it in 7 quarters since.
Sagespring Wealth Partners's Sanofi position peaked at $710K in Q2 2025.
716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Sagespring Wealth Partners's 13F filing for Q2 2026, filed 3 Aug 2026.